Report cover image

Cardiovascular Surgery Devices

Published May 01, 2026
Length 400 Pages
SKU # GJOB21161906

Description

REPORT HIGHLIGHTS

Global Cardiovascular Surgery Devices Market to Reach US$2.1 Billion by 2032

The global market for Cardiovascular Surgery Devices estimated at US$1.8 Billion in the year 2025, is expected to reach US$2.1 Billion by 2032, growing at a CAGR of 2.8% over the analysis period 2025-2032. Cardiopulmonary Bypass Systems Type, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$554.3 Million by the end of the analysis period. Growth in the Cardiac Ablation Devices Type segment is estimated at 1.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$539.6 Million While China is Forecast to Grow at 5.7% CAGR

The Cardiovascular Surgery Devices market in the U.S. is estimated at US$539.6 Million in the year 2025. China, the world`s second largest economy, is forecast to reach a projected market size of US$506.1 Million by the year 2032 trailing a CAGR of 5.7% over the analysis period 2025-2032. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.1% and 2.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.7% CAGR.

Global Cardiovascular Surgery Devices Market - Key Trends & Drivers Summarized

What Innovations Are Shaping the Cardiovascular Surgery Devices Market?

The cardiovascular surgery devices market is undergoing a transformative phase characterized by rapid advancements in medical technology and innovative surgical approaches. From minimally invasive surgical devices to robotic-assisted systems, there is a significant shift towards equipment that reduces recovery times and improves patient outcomes. The advent of devices like transcatheter aortic valve replacement (TAVR) and percutaneous coronary intervention (PCI) systems has redefined the treatment landscape, minimizing the need for traditional open-heart surgeries. Moreover, the integration of AI and machine learning in surgery devices is enhancing precision, leading to better procedural success rates and lower complication risks. These advancements are not only elevating the standard of care but also increasing the adoption rate among healthcare providers worldwide.

Why Is There a Rising Demand for Cardiovascular Surgery Devices?

The demand for cardiovascular surgery devices is escalating, driven by a surge in cardiovascular diseases (CVDs) globally, which remain a leading cause of mortality. Sedentary lifestyles, unhealthy diets, and rising obesity rates are contributing to the prevalence of heart diseases, thereby increasing the need for effective surgical interventions. Additionally, aging populations in regions such as North America, Europe, and parts of Asia-Pacific are adding to the burden of CVDs, necessitating more surgeries and hence more advanced surgical devices. Hospitals and surgical centers are increasingly investing in technologically advanced devices to meet the growing patient inflow and ensure superior clinical outcomes. This surge is further bolstered by an increasing awareness among the public about the availability and benefits of modern surgical techniques, pushing the market growth even further.

How Are Regulatory Approvals and Reimbursements Impacting the Market?

Regulatory landscapes and reimbursement policies play a pivotal role in shaping the cardiovascular surgery devices market. With stringent regulations in place, particularly in developed economies, companies are compelled to invest heavily in research and development to innovate products that meet safety and efficacy standards. The approval processes by agencies like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) are crucial milestones for any new device, influencing their market entry and acceptance. On the other hand, favorable reimbursement policies in countries like the U.S., Germany, and Japan are making advanced cardiovascular surgeries more accessible to patients, thereby encouraging healthcare facilities to upgrade their surgical equipment. These factors collectively influence the overall dynamics, offering both opportunities and challenges for key market players.

What Are the Drivers Behind the Market Growth for Cardiovascular Surgery Devices?

The growth in the cardiovascular surgery devices market is driven by several factors, including technological advancements, an aging global population, and an increasing incidence of cardiovascular diseases. The shift towards minimally invasive surgeries, driven by patient preference for reduced pain and quicker recovery, is significantly bolstering the market. Enhanced healthcare infrastructure in emerging markets, coupled with increasing healthcare expenditure, is enabling the adoption of advanced surgical devices. The rising trend of hybrid operating rooms, which combine traditional and minimally invasive surgeries, is another catalyst, creating demand for sophisticated surgical devices. Furthermore, increasing government initiatives to improve healthcare access and growing investments in healthcare technologies by private players are providing strong support to market expansion. Together, these elements form a comprehensive growth framework, propelling the cardiovascular surgery devices market forward.

SCOPE OF STUDY:

The report analyzes the Cardiovascular Surgery Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Type (Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type, Other Types); Indication (Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication, Arrhythmia-related Procedures Indication); End-Use (Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use, Academic & Research Institutes End-Use)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

SELECT PLAYERS -
  • Abbott
  • Artivion, Inc
  • Betamed srl
  • Bonameda, LLC
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Dolphin Surgicals
  • Edwards Lifesciences Corporation
  • InSitu Technologies, Inc.
  • Intra Special Catheters GmbH
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

Table of Contents

400 Pages
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind
How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind
Cardiovascular Surgery Devices – Global Key Competitors Percentage Market Share in 2026 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2026 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Incidence of Cardiovascular Diseases Driving Demand for Surgical Devices
Technological Advancements in Minimally Invasive Cardiovascular Surgery Devices
Growth in the Use of Robotic-Assisted Surgery Devices for Cardiac Procedures
Increasing Adoption of Advanced Cardiopulmonary Bypass and Oxygenation Systems
Impact of Aging Population on Demand for Cardiovascular Surgery Interventions
Expansion of Hybrid Operating Rooms Boosting Demand for Advanced Surgical Tools
Growing Focus on Personalized Medicine and Customizable Surgical Devices
Rising Investments in R&D for Innovative Cardiovascular Surgery Devices
Increasing Demand for Portable and Compact Cardiovascular Monitoring Devices
Growth in Telemedicine and Remote Cardiac Surgery Capabilities
Expanding Healthcare Infrastructure in Emerging Markets Driving Market Opportunities
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Cardiovascular Surgery Devices Market Analysis of Annual Sales in US$ Thousand for Years 2020 through 2032
TABLE 2: World Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
TABLE 3: World Historic Review for Cardiovascular Surgery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 4: World 13-Year Perspective for Cardiovascular Surgery Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
TABLE 5: World Recent Past, Current & Future Analysis for Cardiopulmonary Bypass Systems Type by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
TABLE 6: World Historic Review for Cardiopulmonary Bypass Systems Type by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 7: World 13-Year Perspective for Cardiopulmonary Bypass Systems Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 8: World Recent Past, Current & Future Analysis for Cardiac Ablation Devices Type by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
TABLE 9: World Historic Review for Cardiac Ablation Devices Type by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 10: World 13-Year Perspective for Cardiac Ablation Devices Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 11: World Recent Past, Current & Future Analysis for Artificial Heart Valves Type by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
TABLE 12: World Historic Review for Artificial Heart Valves Type by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 13: World 13-Year Perspective for Artificial Heart Valves Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 14: World Recent Past, Current & Future Analysis for Ventricular Assist Devices Type by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
TABLE 15: World Historic Review for Ventricular Assist Devices Type by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 16: World 13-Year Perspective for Ventricular Assist Devices Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 17: World Recent Past, Current & Future Analysis for Implantable Rhythm Management Devices Type by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
TABLE 18: World Historic Review for Implantable Rhythm Management Devices Type by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 19: World 13-Year Perspective for Implantable Rhythm Management Devices Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 20: World Recent Past, Current & Future Analysis for Surgical Instruments Type by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
TABLE 21: World Historic Review for Surgical Instruments Type by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 22: World 13-Year Perspective for Surgical Instruments Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 23: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
TABLE 24: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 25: World 13-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 26: World Recent Past, Current & Future Analysis for Coronary Procedures Indication by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
TABLE 27: World Historic Review for Coronary Procedures Indication by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 28: World 13-Year Perspective for Coronary Procedures Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 29: World Recent Past, Current & Future Analysis for Valve Procedures Indication by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
TABLE 30: World Historic Review for Valve Procedures Indication by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 31: World 13-Year Perspective for Valve Procedures Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 32: World Recent Past, Current & Future Analysis for Transplant & Replacement Procedures Indication by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
TABLE 33: World Historic Review for Transplant & Replacement Procedures Indication by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 34: World 13-Year Perspective for Transplant & Replacement Procedures Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 35: World Recent Past, Current & Future Analysis for Arrhythmia-related Procedures Indication by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
TABLE 36: World Historic Review for Arrhythmia-related Procedures Indication by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 37: World 13-Year Perspective for Arrhythmia-related Procedures Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 38: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
TABLE 39: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 40: World 13-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 41: World Recent Past, Current & Future Analysis for Cardiac Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
TABLE 42: World Historic Review for Cardiac Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 43: World 13-Year Perspective for Cardiac Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 44: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
TABLE 45: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 46: World 13-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 47: World Recent Past, Current & Future Analysis for Cardiac Catheterization Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
TABLE 48: World Historic Review for Cardiac Catheterization Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 49: World 13-Year Perspective for Cardiac Catheterization Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
TABLE 50: World Recent Past, Current & Future Analysis for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
TABLE 51: World Historic Review for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 52: World 13-Year Perspective for Academic & Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
III. MARKET ANALYSIS
UNITED STATES
Cardiovascular Surgery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
TABLE 53: USA Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 54: USA Historic Review for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 55: USA 13-Year Perspective for Cardiovascular Surgery Devices by Type - Percentage Breakdown of Value Sales for Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types for the Years 2020, 2026 & 2032
TABLE 56: USA Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 57: USA Historic Review for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 58: USA 13-Year Perspective for Cardiovascular Surgery Devices by Indication - Percentage Breakdown of Value Sales for Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication for the Years 2020, 2026 & 2032
TABLE 59: USA Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 60: USA Historic Review for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 61: USA 13-Year Perspective for Cardiovascular Surgery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2020, 2026 & 2032
CANADA
TABLE 62: Canada Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 63: Canada Historic Review for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 64: Canada 13-Year Perspective for Cardiovascular Surgery Devices by Type - Percentage Breakdown of Value Sales for Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types for the Years 2020, 2026 & 2032
TABLE 65: Canada Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 66: Canada Historic Review for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 67: Canada 13-Year Perspective for Cardiovascular Surgery Devices by Indication - Percentage Breakdown of Value Sales for Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication for the Years 2020, 2026 & 2032
TABLE 68: Canada Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 69: Canada Historic Review for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 70: Canada 13-Year Perspective for Cardiovascular Surgery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2020, 2026 & 2032
JAPAN
Cardiovascular Surgery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
TABLE 71: Japan Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 72: Japan Historic Review for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 73: Japan 13-Year Perspective for Cardiovascular Surgery Devices by Type - Percentage Breakdown of Value Sales for Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types for the Years 2020, 2026 & 2032
TABLE 74: Japan Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 75: Japan Historic Review for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 76: Japan 13-Year Perspective for Cardiovascular Surgery Devices by Indication - Percentage Breakdown of Value Sales for Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication for the Years 2020, 2026 & 2032
TABLE 77: Japan Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 78: Japan Historic Review for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 79: Japan 13-Year Perspective for Cardiovascular Surgery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2020, 2026 & 2032
CHINA
Cardiovascular Surgery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
TABLE 80: China Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 81: China Historic Review for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 82: China 13-Year Perspective for Cardiovascular Surgery Devices by Type - Percentage Breakdown of Value Sales for Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types for the Years 2020, 2026 & 2032
TABLE 83: China Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 84: China Historic Review for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 85: China 13-Year Perspective for Cardiovascular Surgery Devices by Indication - Percentage Breakdown of Value Sales for Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication for the Years 2020, 2026 & 2032
TABLE 86: China Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 87: China Historic Review for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 88: China 13-Year Perspective for Cardiovascular Surgery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2020, 2026 & 2032
EUROPE
Cardiovascular Surgery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
TABLE 89: Europe Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
TABLE 90: Europe Historic Review for Cardiovascular Surgery Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 91: Europe 13-Year Perspective for Cardiovascular Surgery Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2020, 2026 & 2032
TABLE 92: Europe Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 93: Europe Historic Review for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 94: Europe 13-Year Perspective for Cardiovascular Surgery Devices by Type - Percentage Breakdown of Value Sales for Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types for the Years 2020, 2026 & 2032
TABLE 95: Europe Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 96: Europe Historic Review for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 97: Europe 13-Year Perspective for Cardiovascular Surgery Devices by Indication - Percentage Breakdown of Value Sales for Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication for the Years 2020, 2026 & 2032
TABLE 98: Europe Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 99: Europe Historic Review for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 100: Europe 13-Year Perspective for Cardiovascular Surgery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2020, 2026 & 2032
FRANCE
Cardiovascular Surgery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
TABLE 101: France Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 102: France Historic Review for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 103: France 13-Year Perspective for Cardiovascular Surgery Devices by Type - Percentage Breakdown of Value Sales for Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types for the Years 2020, 2026 & 2032
TABLE 104: France Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 105: France Historic Review for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 106: France 13-Year Perspective for Cardiovascular Surgery Devices by Indication - Percentage Breakdown of Value Sales for Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication for the Years 2020, 2026 & 2032
TABLE 107: France Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 108: France Historic Review for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 109: France 13-Year Perspective for Cardiovascular Surgery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2020, 2026 & 2032
GERMANY
Cardiovascular Surgery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
TABLE 110: Germany Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 111: Germany Historic Review for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 112: Germany 13-Year Perspective for Cardiovascular Surgery Devices by Type - Percentage Breakdown of Value Sales for Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types for the Years 2020, 2026 & 2032
TABLE 113: Germany Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 114: Germany Historic Review for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 115: Germany 13-Year Perspective for Cardiovascular Surgery Devices by Indication - Percentage Breakdown of Value Sales for Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication for the Years 2020, 2026 & 2032
TABLE 116: Germany Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 117: Germany Historic Review for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 118: Germany 13-Year Perspective for Cardiovascular Surgery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2020, 2026 & 2032
ITALY
TABLE 119: Italy Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 120: Italy Historic Review for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 121: Italy 13-Year Perspective for Cardiovascular Surgery Devices by Type - Percentage Breakdown of Value Sales for Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types for the Years 2020, 2026 & 2032
TABLE 122: Italy Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 123: Italy Historic Review for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 124: Italy 13-Year Perspective for Cardiovascular Surgery Devices by Indication - Percentage Breakdown of Value Sales for Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication for the Years 2020, 2026 & 2032
TABLE 125: Italy Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 126: Italy Historic Review for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 127: Italy 13-Year Perspective for Cardiovascular Surgery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2020, 2026 & 2032
UNITED KINGDOM
Cardiovascular Surgery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
TABLE 128: UK Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 129: UK Historic Review for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 130: UK 13-Year Perspective for Cardiovascular Surgery Devices by Type - Percentage Breakdown of Value Sales for Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types for the Years 2020, 2026 & 2032
TABLE 131: UK Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 132: UK Historic Review for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 133: UK 13-Year Perspective for Cardiovascular Surgery Devices by Indication - Percentage Breakdown of Value Sales for Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication for the Years 2020, 2026 & 2032
TABLE 134: UK Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 135: UK Historic Review for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 136: UK 13-Year Perspective for Cardiovascular Surgery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2020, 2026 & 2032
SPAIN
TABLE 137: Spain Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 138: Spain Historic Review for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 139: Spain 13-Year Perspective for Cardiovascular Surgery Devices by Type - Percentage Breakdown of Value Sales for Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types for the Years 2020, 2026 & 2032
TABLE 140: Spain Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 141: Spain Historic Review for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 142: Spain 13-Year Perspective for Cardiovascular Surgery Devices by Indication - Percentage Breakdown of Value Sales for Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication for the Years 2020, 2026 & 2032
TABLE 143: Spain Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 144: Spain Historic Review for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 145: Spain 13-Year Perspective for Cardiovascular Surgery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2020, 2026 & 2032
RUSSIA
TABLE 146: Russia Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 147: Russia Historic Review for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 148: Russia 13-Year Perspective for Cardiovascular Surgery Devices by Type - Percentage Breakdown of Value Sales for Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types for the Years 2020, 2026 & 2032
TABLE 149: Russia Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 150: Russia Historic Review for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 151: Russia 13-Year Perspective for Cardiovascular Surgery Devices by Indication - Percentage Breakdown of Value Sales for Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication for the Years 2020, 2026 & 2032
TABLE 152: Russia Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 153: Russia Historic Review for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 154: Russia 13-Year Perspective for Cardiovascular Surgery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2020, 2026 & 2032
REST OF EUROPE
TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 156: Rest of Europe Historic Review for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 157: Rest of Europe 13-Year Perspective for Cardiovascular Surgery Devices by Type - Percentage Breakdown of Value Sales for Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types for the Years 2020, 2026 & 2032
TABLE 158: Rest of Europe Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 159: Rest of Europe Historic Review for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 160: Rest of Europe 13-Year Perspective for Cardiovascular Surgery Devices by Indication - Percentage Breakdown of Value Sales for Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication for the Years 2020, 2026 & 2032
TABLE 161: Rest of Europe Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 162: Rest of Europe Historic Review for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 163: Rest of Europe 13-Year Perspective for Cardiovascular Surgery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2020, 2026 & 2032
AUSTRALIA
Cardiovascular Surgery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
INDIA
Cardiovascular Surgery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
SOUTH KOREA
REST OF ASIA-PACIFIC
LATIN AMERICA
Cardiovascular Surgery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
TABLE 164: Latin America Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
TABLE 165: Latin America Historic Review for Cardiovascular Surgery Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 166: Latin America 13-Year Perspective for Cardiovascular Surgery Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2020, 2026 & 2032
TABLE 167: Latin America Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 168: Latin America Historic Review for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 169: Latin America 13-Year Perspective for Cardiovascular Surgery Devices by Type - Percentage Breakdown of Value Sales for Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types for the Years 2020, 2026 & 2032
TABLE 170: Latin America Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 171: Latin America Historic Review for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 172: Latin America 13-Year Perspective for Cardiovascular Surgery Devices by Indication - Percentage Breakdown of Value Sales for Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication for the Years 2020, 2026 & 2032
TABLE 173: Latin America Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 174: Latin America Historic Review for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 175: Latin America 13-Year Perspective for Cardiovascular Surgery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2020, 2026 & 2032
ARGENTINA
TABLE 176: Argentina Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 177: Argentina Historic Review for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 178: Argentina 13-Year Perspective for Cardiovascular Surgery Devices by Type - Percentage Breakdown of Value Sales for Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types for the Years 2020, 2026 & 2032
TABLE 179: Argentina Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 180: Argentina Historic Review for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 181: Argentina 13-Year Perspective for Cardiovascular Surgery Devices by Indication - Percentage Breakdown of Value Sales for Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication for the Years 2020, 2026 & 2032
TABLE 182: Argentina Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 183: Argentina Historic Review for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 184: Argentina 13-Year Perspective for Cardiovascular Surgery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2020, 2026 & 2032
BRAZIL
TABLE 185: Brazil Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 186: Brazil Historic Review for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 187: Brazil 13-Year Perspective for Cardiovascular Surgery Devices by Type - Percentage Breakdown of Value Sales for Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types for the Years 2020, 2026 & 2032
TABLE 188: Brazil Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 189: Brazil Historic Review for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 190: Brazil 13-Year Perspective for Cardiovascular Surgery Devices by Indication - Percentage Breakdown of Value Sales for Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication for the Years 2020, 2026 & 2032
TABLE 191: Brazil Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 192: Brazil Historic Review for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 193: Brazil 13-Year Perspective for Cardiovascular Surgery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2020, 2026 & 2032
MEXICO
TABLE 194: Mexico Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 195: Mexico Historic Review for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 196: Mexico 13-Year Perspective for Cardiovascular Surgery Devices by Type - Percentage Breakdown of Value Sales for Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types for the Years 2020, 2026 & 2032
TABLE 197: Mexico Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 198: Mexico Historic Review for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 199: Mexico 13-Year Perspective for Cardiovascular Surgery Devices by Indication - Percentage Breakdown of Value Sales for Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication for the Years 2020, 2026 & 2032
TABLE 200: Mexico Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 201: Mexico Historic Review for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 202: Mexico 13-Year Perspective for Cardiovascular Surgery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2020, 2026 & 2032
REST OF LATIN AMERICA
TABLE 203: Rest of Latin America Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 204: Rest of Latin America Historic Review for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 205: Rest of Latin America 13-Year Perspective for Cardiovascular Surgery Devices by Type - Percentage Breakdown of Value Sales for Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types for the Years 2020, 2026 & 2032
TABLE 206: Rest of Latin America Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 207: Rest of Latin America Historic Review for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 208: Rest of Latin America 13-Year Perspective for Cardiovascular Surgery Devices by Indication - Percentage Breakdown of Value Sales for Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication for the Years 2020, 2026 & 2032
TABLE 209: Rest of Latin America Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 210: Rest of Latin America Historic Review for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 211: Rest of Latin America 13-Year Perspective for Cardiovascular Surgery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2020, 2026 & 2032
MIDDLE EAST
Cardiovascular Surgery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
TABLE 212: Middle East Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
TABLE 213: Middle East Historic Review for Cardiovascular Surgery Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 214: Middle East 13-Year Perspective for Cardiovascular Surgery Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2020, 2026 & 2032
TABLE 215: Middle East Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 216: Middle East Historic Review for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 217: Middle East 13-Year Perspective for Cardiovascular Surgery Devices by Type - Percentage Breakdown of Value Sales for Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types for the Years 2020, 2026 & 2032
TABLE 218: Middle East Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 219: Middle East Historic Review for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 220: Middle East 13-Year Perspective for Cardiovascular Surgery Devices by Indication - Percentage Breakdown of Value Sales for Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication for the Years 2020, 2026 & 2032
TABLE 221: Middle East Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 222: Middle East Historic Review for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 223: Middle East 13-Year Perspective for Cardiovascular Surgery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2020, 2026 & 2032
IRAN
TABLE 224: Iran Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 225: Iran Historic Review for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 226: Iran 13-Year Perspective for Cardiovascular Surgery Devices by Type - Percentage Breakdown of Value Sales for Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types for the Years 2020, 2026 & 2032
TABLE 227: Iran Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 228: Iran Historic Review for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 229: Iran 13-Year Perspective for Cardiovascular Surgery Devices by Indication - Percentage Breakdown of Value Sales for Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication for the Years 2020, 2026 & 2032
TABLE 230: Iran Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 231: Iran Historic Review for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 232: Iran 13-Year Perspective for Cardiovascular Surgery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2020, 2026 & 2032
ISRAEL
TABLE 233: Israel Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 234: Israel Historic Review for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 235: Israel 13-Year Perspective for Cardiovascular Surgery Devices by Type - Percentage Breakdown of Value Sales for Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types for the Years 2020, 2026 & 2032
TABLE 236: Israel Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 237: Israel Historic Review for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 238: Israel 13-Year Perspective for Cardiovascular Surgery Devices by Indication - Percentage Breakdown of Value Sales for Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication for the Years 2020, 2026 & 2032
TABLE 239: Israel Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 240: Israel Historic Review for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 241: Israel 13-Year Perspective for Cardiovascular Surgery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2020, 2026 & 2032
SAUDI ARABIA
TABLE 242: Saudi Arabia Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 243: Saudi Arabia Historic Review for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 244: Saudi Arabia 13-Year Perspective for Cardiovascular Surgery Devices by Type - Percentage Breakdown of Value Sales for Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types for the Years 2020, 2026 & 2032
TABLE 245: Saudi Arabia Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 246: Saudi Arabia Historic Review for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 247: Saudi Arabia 13-Year Perspective for Cardiovascular Surgery Devices by Indication - Percentage Breakdown of Value Sales for Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication for the Years 2020, 2026 & 2032
TABLE 248: Saudi Arabia Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 249: Saudi Arabia Historic Review for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 250: Saudi Arabia 13-Year Perspective for Cardiovascular Surgery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2020, 2026 & 2032
UNITED ARAB EMIRATES
TABLE 251: UAE Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 252: UAE Historic Review for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 253: UAE 13-Year Perspective for Cardiovascular Surgery Devices by Type - Percentage Breakdown of Value Sales for Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types for the Years 2020, 2026 & 2032
TABLE 254: UAE Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 255: UAE Historic Review for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 256: UAE 13-Year Perspective for Cardiovascular Surgery Devices by Indication - Percentage Breakdown of Value Sales for Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication for the Years 2020, 2026 & 2032
TABLE 257: UAE Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 258: UAE Historic Review for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 259: UAE 13-Year Perspective for Cardiovascular Surgery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2020, 2026 & 2032
REST OF MIDDLE EAST
TABLE 260: Rest of Middle East Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 261: Rest of Middle East Historic Review for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 262: Rest of Middle East 13-Year Perspective for Cardiovascular Surgery Devices by Type - Percentage Breakdown of Value Sales for Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types for the Years 2020, 2026 & 2032
TABLE 263: Rest of Middle East Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 264: Rest of Middle East Historic Review for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 265: Rest of Middle East 13-Year Perspective for Cardiovascular Surgery Devices by Indication - Percentage Breakdown of Value Sales for Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication for the Years 2020, 2026 & 2032
TABLE 266: Rest of Middle East Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 267: Rest of Middle East Historic Review for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 268: Rest of Middle East 13-Year Perspective for Cardiovascular Surgery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2020, 2026 & 2032
AFRICA
Cardiovascular Surgery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
TABLE 269: Africa Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 270: Africa Historic Review for Cardiovascular Surgery Devices by Type - Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 271: Africa 13-Year Perspective for Cardiovascular Surgery Devices by Type - Percentage Breakdown of Value Sales for Cardiopulmonary Bypass Systems Type, Cardiac Ablation Devices Type, Artificial Heart Valves Type, Ventricular Assist Devices Type, Implantable Rhythm Management Devices Type, Surgical Instruments Type and Other Types for the Years 2020, 2026 & 2032
TABLE 272: Africa Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 273: Africa Historic Review for Cardiovascular Surgery Devices by Indication - Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 274: Africa 13-Year Perspective for Cardiovascular Surgery Devices by Indication - Percentage Breakdown of Value Sales for Coronary Procedures Indication, Valve Procedures Indication, Transplant & Replacement Procedures Indication and Arrhythmia-related Procedures Indication for the Years 2020, 2026 & 2032
TABLE 275: Africa Recent Past, Current & Future Analysis for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
TABLE 276: Africa Historic Review for Cardiovascular Surgery Devices by End-Use - Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
TABLE 277: Africa 13-Year Perspective for Cardiovascular Surgery Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Cardiac Centers End-Use, Ambulatory Surgery Centers End-Use, Cardiac Catheterization Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2020, 2026 & 2032
IV. COMPETITION
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.